To determine whether a temporal association exists between antecedent packed red blood cell (PRBC) transfusions and necrotizing enterocolitis (NEC) in premature infants. STUDY DESIGN: This case-control study included inborn infants from a single center who developed NEC during a 2-year period. For every NEC infant, two matched controls from the same period were chosen based on gestational age and birth weight. Transfusion-related NEC was defined as antecedent PRBC transfusion within 48 h prior to the onset of any symptoms attributable to NEC. Bivariate analyses were used to compare baseline characteristics of all infants. To determine the raw odds ratio for the presence of exposure (transfusion) versus outcome (NEC), the hospital course (ages 6 to 63 days) of all study infants was divided into 48-h epochs; occurrence of transfusion and NEC was noted within each epoch. Generalized estimating equations were used to estimate the adjusted odds for developing NEC within an epoch with and without antecedent transfusion, controlling chronological age within infant as well as for gestational age, gender, feeding status in prior 48-h epoch and indicators of disease severity. RESULT: There were 3652 48-h epochs and 557 transfusions among 49 NEC infants and 97 controls; 17 infants had transfusionrelated NEC, yielding a raw odds ratio of 3.01 (Po0.001). The adjusted odds ratios were 2.97 (P ¼ 0.003) for transfusion and 2.76 (P ¼ 0.05) for feeding status in the prior 48-h epoch. Infants who were being fed in the 48-h period prior to transfusion were more than eight times more likely to develop NEC than infants who were neither fed nor transfused. CONCLUSION: Antecedent PRBC transfusion appears to be an independent risk factor for developing NEC during the subsequent 48-h period.
INTRODUCTION
The relationship between packed red blood cell (PRBC) transfusion and the development of necrotizing enterocolitis (NEC) has been a controversial topic for nearly 3 decades. In the 1980 to 1990s, several observational studies noted an association between blood transfusion and NEC that appeared to be related to erythrocyte T antigen activation. [1] [2] [3] [4] As a result, clinicians were advised to use blood products free of plasma, and to reduce infants' exposure to immunoglobulin and white cells in blood given to preterm infants. Currently, most preterm infants are transfused PRBCs, which are leukoreduced, irradiated and cytomegalovirus antibody negative. Despite these precautions, reports of the occurrence of a temporal association between NEC and PRBC transfusion persist, [5] [6] [7] [8] raising the question of whether PRBC transfusion poses a risk factor for the development of NEC.
In the neonatal intensive care unit (NICU), small premature infants may be transfused for a variety of reasons. Transfusions may be given for anemia accompanying exacerbations of severe illnesses such as sepsis, NEC or respiratory distress syndrome, or for subtle increases in symptoms of cardiorespiratory instability in a stable, growing infant. However, premature infants may have delayed or inadequate erythropoiesis, and transfusions may also be given pre-emptively in response to severe physiologic anemia or to replace the accumulated volume blood drawn for laboratory testing. Thus, several challenges confront the investigator who seeks to use epidemiologic data to establish the association between antecedent transfusion and NEC. Susceptibility to NEC may change over the course of an infant's hospitalization and may be influenced by antecedent history of illness and feeding status. Premature infants have a limited symptom repertoire to manifest disparate illnesses with complex pathophysiologies; the symptoms of anemia that may justify a transfusion often resemble early indicators of NEC. It may be difficult to determine retrospectively, or even prospectively, whether a transfusion preceded the onset of NEC, and thus might have caused it, or was given as a result of symptoms related to the disease.
This study explores several strategies to deal with these challenges. In order to provide a basis for comparing rates of occurrence of transfusion and non-transfusion-related NEC, while controlling for the effects of chronologic age, gestational age and markers of illness severity, we divided each infant's hospitalization into 48-h epochs. We used these epochs as the unit of analysis in bivariate and multivariate mixed effects analyses that controlled for chronological age of the patient. We restricted the definition of transfusion-associated NEC to include only those cases of NEC in which a temporarily related transfusion clearly preceded any symptoms that might have been attributable to NEC. When any symptom possibly related to NEC preceded the transfusion, the transfusion was considered non-transfusion-associated. With this definition we created an a priori bias toward the null hypothesis of no association between NEC and transfusion, in the hope of providing more convincing evidence of a true association (if one were found) than has previously been presented.
METHODS
Medical records were reviewed to identify inborn, very low birth weight (o1500 g) preterm infants admitted to the NICU at Morgan Stanley Children's Hospital of New York between January 2005 and December 2007 who developed NEC. For every NEC infant, two matched controls were chosen based on gestational age of ± 1 week and birth weight of ± 100 g. We identified 49 infants with NEC, and 97 infants with similar gestational ages and birth weights during this same period. For one NEC infant, only one matched control could be identified. Infants with congenital malformations were excluded from this study. The chart review included information on gestational age, birth weight, gender, ethnicity, feeding history, respiratory status, status of patent ductus arteriosus and each infant's entire blood transfusion history during the course of the NICU stay. This study was approved by the Institutional Review Board at the Columbia University (IRB no. AAAE1060).
Definition of NEC
The definition of NEC was based on clear radiographic evidence of pneumatosis, portal air and/or surgical pathology, consistent with Bell stage II to III disease. 9, 10 The onset of NEC was defined by a change in clinical status prior to the diagnosis of NEC. These symptoms included an increase in the number of apnea or bradycardia episodes, increase oxygen requirement, abdominal distention and gastric aspirates. We defined transfusion-related NEC as the occurrence of transfusion within 48 h prior to the onset of any symptoms possibly attributable to NEC. Only the first episode of NEC was included in this study and all recurrent NEC episodes were excluded.
Timing of NEC
In preterm infants, the incidence of NEC is inversely proportional to gestational age, and peaks between ages 9 and 38 days, with a range from 2 to 56 days. [11] [12] [13] [14] [15] [16] To include all relevant episodes of NEC, we arbitrarily selected a time period, which included all NEC cases that occurred between 1 and 9 weeks of life (ages 6 to 63 days). This was done to exclude spontaneous perforations with or without tissue necrosis, which usually occur in the first week of life. Spontaneous perforations were also excluded on the basis of intraoperative examination and surgical pathology. As NEC sometimes occurs in clusters, we used exploratory clustering algorithms to assess possible clustering within 30-day intervals. NEC cases were distributed evenly over the study period; no clustering was observed.
Epochs
We created the epochs as follows: for each infant, the 6 to 63-day period was divided into 48-h epochs, corresponding to 2 calendar days. Each infant had 29 epochs. We chose 48 h as a reasonable upper limit for the temporal association between NEC and transfusion. After placing all the cases of NEC and all the transfusions into their respective epochs, one of us (PW) carefully reviewed the NEC cases to make the following determinations:
(1) If a transfusion preceded NEC within 48 h (real hours, not calendar days) then that transfusion was a candidate to occupy the same epoch as NEC. (2) However, if the baby had any symptoms that could have conceivably been indicators of incipient NEC prior to the transfusion, then that transfusion was not allowed to occupy the same epoch as NEC. If the baby had no such symptoms, then antecedent transfusion and NEC were allowed to occupy the same epoch. (3) Any transfusion occurring within 48 h of NEC that was given after the onset of NEC was moved to the next epoch, so that it would be considered non-transfusion-related. (4) All subsequent transfusions in an infant who had NEC were considered non-NEC-related, even if they were given while an infant was being treated for NEC, or one of them could have caused a second episode of NEC.
Feeding status
The presence of any exposure to enteral feeding was noted within each epoch. During the study period, our NICU had no consistent practice regarding the continuation or interruption of feeding during transfusions.
Thus, the feeding status in the prior 48-h epoch was used to determine feeding status at the time of transfusion.
Blood transfusions
During this time period, our institution did not have a strict transfusion protocol in place. However, the practice consistently followed was to transfuse 15 ml kg À 1 PRBC over 4 h. Our nursing staff had a protocol in place to obtain vital signs every 15 min and to evaluate IV patency during the transfusion.
Indicators of disease severity
In order to account for confounding factors, additional risk factors that may represent a marker of increased susceptibility to NEC were included in each epoch. These indicators included symptomatic PDA, infection (sepsis, urinary tract infection or phlebitis), pressor use, receipt of mechanical ventilation and exposure to inspired oxygen 440%.
Statistical analysis
We used bivariate analyses to compare the baseline characteristics of NEC infants and matched controls. We used a 2 Â 2 contingency table, with epoch as the unit of analysis to compute the raw odds ratio of NEC vs PRBC transfusion. This calculation assumes that the probability of being exposed to PRBC and that of developing NEC do not differ across epochs. We tested the validity of this assumption using logistic models that regressed the occurrence of NEC and transfusion against the week of life (excluding week 1, which had very few NEC cases and transfusions). These models indicated that the odds of developing NEC decreased by 9% per week (Po0.001) and the odds of receiving a transfusion decreased by 20% per week (Po0.001). To compensate for these and other effects, we used logistic generalized estimating equations to estimate the adjusted odds ratio for developing NEC within each epoch with and without antecedent transfusion, controlling for chronological age by epoch within infant (SPSS ver 20, IBM Corporation, Armonk, NY, USA). These models included gestational age, gender, chronological age, enteral feeding status by prior epoch and the indicators of disease severity noted above. The unequal distribution of risk factors of disease severity between the categories of the exposure of interest (transfusion) represents a potential source of confounding. To compensate, we added a propensity score to the model, which represents the conditional probability of being transfused, given the other risk factors in the model. 17 The score was derived as the vector of predicted mean values resulting from the logistic regression of transfusion on risk factors, with epoch as the unit of analysis.
RESULTS
A summary of the characteristics of the 49 infants with NEC and the 97 matched control infants is shown in Table 1. Table 2 shows the 2 Â 2 contingency table used to compute the association between NEC and antecedent transfusion within epochs. There were a total of 3652 48-h epochs, 557 of which included blood transfusions among all study infants. Seventeen of the fourty-nine cases of NEC were considered transfusion-related, yielding a raw odds ratio (95% confidence interval) of 3.01 (1.67, 5.47, Po0.001).
Infants who died (n ¼ 8) or were transferred (n ¼ 5) or discharged home (n ¼ 26) prior to the end of the study duration had fewer epochs than infants who remained hospitalized for the duration of the study. To estimate the effect of these 'missing epochs' on the magnitude of the odds ratio, we calculated the additional numbers of non-transfusion-related NEC cases and non-NEC-related transfusions these infants would have had, had they remained alive and hospitalized through the end of the study period, using gestational age-, outcome-and epoch-specific NEC and transfusion rates for each infant's absent period. This analysis adds three non-transfusion-related cases of NEC, 91 non-NECrelated transfusions and 482 non-transfusion, non-NEC epochs to the appropriate cells in the 2 Â 2 contingency table, yielding an odds ratio (95% confidence interval) of 2.70 (1.51, 4.85, Po0.001). Table 3 displays parameter estimates produced by the logistic generalized estimating equation controlling for gestational age, feeding status in the prior 48-h epoch, propensity score and the within-subject effect of chronological age in epochs. After removing nonsignificant predictors, including sex, chronological age and indicators of disease severity, the adjusted odds ratios (95% confidence interval) were 2.97 (1.46, 6.05, P ¼ 0.003) for transfusion and 2.76 (1.00, 7.64, P ¼ 0.05) for feeding status in the prior 48-h epoch. Replacing the main effects terms by an interaction term for transfusion and feeding status in the prior epoch yielded odds ratios of 8.68 (2.45, 30.8, P ¼ 0.001) for transfusion with feeding and 2.85 (1.24, 6.55, P ¼ 0.013) for transfusion without feeding, when compared with the reference category (the odds of NEC without feeding and without transfusion). This means that infants who were being fed in the 48-h epoch prior to transfusion were more than eight times more likely to develop NEC than infants who were neither fed nor transfused, and more than three times more likely than those being fed but not transfused.
DISCUSSION
Previous studies have shown an association between PRBC transfusion and NEC, however, it has always been unclear whether infants who were transfused for symptomatic anemia were manifesting early signs of NEC. [11] [12] [13] [14] [15] [16] Our study confirms the PRBC as a risk factor for NEC P Wan-Huen et al association between antecedent PRBC transfusion and NEC, even after excluding those cases in which it was unclear if transfusion was given for symptomatic anemia or developing NEC. This may underestimate our incidence of transfusion-related NEC, but it strengthens the case that PRBC transfusion is an independent risk factor for NEC. The magnitude and strength of this association persist in multivariate models controlling for chronologic age of infant and indicators of illness severity. Several theories on the mechanism by which NEC may develop after PRBC transfusion have been proposed. Blood transfusion is known to cause an inflammatory response, whether immune-or non-immune-mediated. 18 Although no specific cytokine markers for NEC have been identified, its pathogenesis includes inflammation; thus, NEC could represent such a transfusion reaction. The relationship between feeding before and during a blood transfusion has also been postulated as a potential risk factor for transfusion-related NEC. Christensen et al. 13 and Paul et al.
19
could not demonstrate this relationship. However, El Dib et al. 16 reported a decrease in the incidence of NEC after implementing a policy of withholding feeds during blood transfusions in their NICU. In addition, Gretchen et al. 20 have shown that post-prandial mesenteric flow during bolus feeding is altered by PRBC transfusion, which can compromise perfusion and oxygenation in the gut. In our study, the association between NEC and antecedent transfusion was enhanced if infants had received enteral feeding within the preceding epoch. Note that feeding status within the NEC-onset epoch was not included in the analysis because our unit had no consistent practice regarding continuation or interruption of feeds during transfusion. Thus, our results do not inform the practice of withholding feeds during transfusion.
Alterations in the viscosity of blood following PRBC transfusions have been postulated as a risk factor for NEC, but have been shown only in a limited number of investigations. Nelle et al. 21 demonstrated an increase of blood viscosity by 33% in cerebral arterial vessels and celiac trunk, following transfusion of 10 ml kg À 1 of PRBC, but the vascular hindrance (flow resistance to blood viscosity ratio) did not change. It is unclear how this change in viscosity affects preterm infants and whether it represents a risk factor for NEC.
Source of donor blood, such as female donor blood, has also been associated with certain immune-modulated transfusion reactions such as transfusion-related lung injury. 22 However, Paul et al. 19 found that most transfusion-related NEC cases developed after transfusion from male donors. In adult literature, age of blood seems to be a contributing factor to postoperative complications after cardiac surgery. 23 Blood is preserved for a maximum of 42 days, depending on the preservative used. Older blood contains less 2, 3-diphosphoglycerate, decreasing the oxygen delivery to tissues. Although this process is reversible, it may affect tissue oxygenation when combined with other factors such as a change in viscosity during transfusion. NEC has been induced in mice models through hypoxia/reperfusion methods, which may mimic what anemic infants experience during or immediately after a transfusion. 24 Fergusson et al. 25 recently published their ARIPI (Age of Red Blood Cells in Premature Infants) trial, where they compared outcomes of infants transfused with PRBC p7 days of age and standard transfusion protocols. NEC was one of their primary outcomes, and they saw no difference in occurrence of NEC when transfused with fresh PRBCs. Our study did not directly control for the age of transfused blood; however, for small premature infants in our NICU, a fresh unit of blood is set aside at the time of the initial transfusion; thus, age of blood increases with the postnatal age of baby, which had no significant effect on the occurrence of NEC in our multivariate analysis.
Our study has several possible limitations. First, as in all casecontrol studies, data reliability depended upon the accuracy and availability of documentation; however, we verified the accuracy of all critical data elements using several sources. Second, the details of feeding exposure during the transfusion epoch itself, including volume, type and tolerance, were not documented and might have a role in modifying the susceptibility to NEC. Finally, although we controlled for known confounders in our multivariate analysis, the possibility that an unmeasured variable confounds or modifies the results remains.
CONCLUSION
Antecedent PRBC transfusion within 48 h of the onset of NEC appears to be an independent risk factor for the development of NEC in premature infants. This relationship cannot be concluded to be the cause and effect. However, these results do provide a basis for several paths of future research. A prospective observational study might better confront the difficulty of deciding if a transfusion is being given for symptoms that reflect early NEC, or for some other cause define markers of illness severity, document the details of feeding and allow for the exploration of biological hypotheses including the roles of age of blood, inflammatory mediators and the role of molecules such as 2, 3-diphosphoglycerate. Future research might also explore the risk/benefit ratio of PRBC transfusion and offer guidelines for transfusing anemic premature infants, who are otherwise stable.
CONFLICT OF INTEREST
The authors declare no conflict of interest.
AUTHOR CONTRIBUTIONS
The first draft was written by Phyllis Wan-Huen. Each author listed on the manuscript has participated in the concept, design, analysis and interpretation of data, drafting or revising of the manuscript, and has seen and approved the submission of this version of the manuscript, and takes full responsibility for its contents.
DISCLAIMER
No external funding was used to support the collection of data, the analysis or the preparation of the manuscript.
